[PAR] YoY Quarter Result on 31-Dec-2019 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2019
Financial Year
2020
Quarter
31-Dec-2019 [#Q2]
Profit Trend
QoQ- 54.54%
YoY- -16.00%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 5 45 0 826 28 22 58 -33.52%
PBT -32,643 -26,985 -20,730 -5,104 -4,400 -3,573 -2,818 50.39%
Tax -776 0 -0 826 0 0 0 -
NP -31,867 -26,985 -20,730 -5,104 -4,400 -3,573 -2,818 49.79%
Tax Rate - - - - - - - -
Total Cost 31,872 27,030 20,730 5,930 4,428 3,596 2,876 49.28%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -676,590.81 -59,701.41 0.00 -617.95 -15,637.06 -15,998.41 -4,891.80 127.32%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.12 -0.11 -0.09 -0.03 -0.03 -0.03 -0.03 25.97%
EPS Diluted -0.12 -0.11 -0.09 -0.03 -0.03 -0.03 -0.03 25.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.